-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IQLd+uMiAICOJ4NCa4C+FI8jfOL1++nOKQ513/mRjslWOIqiDJw3nkrRErR0zGvF Tpk02+Uo4HgzYJq0yo5xUg== 0000754009-96-000003.txt : 19960410 0000754009-96-000003.hdr.sgml : 19960410 ACCESSION NUMBER: 0000754009-96-000003 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960209 SROS: NYSE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SIERRA HEALTH SERVICES INC CENTRAL INDEX KEY: 0000754009 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 880200415 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-38467 FILM NUMBER: 96514305 BUSINESS ADDRESS: STREET 1: 2724 N TENAYA WAY CITY: LAS VEGAS STATE: NV ZIP: 89128 BUSINESS PHONE: 7022427000 MAIL ADDRESS: STREET 2: 2724 NORTH TENAYA WAY CITY: LAS VEGAS STATE: NV ZIP: 89128 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SIERRA HEALTH SERVICES INC CENTRAL INDEX KEY: 0000754009 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 880200415 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 2724 N TENAYA WAY CITY: LAS VEGAS STATE: NV ZIP: 89128 BUSINESS PHONE: 7022427000 MAIL ADDRESS: STREET 2: 2724 NORTH TENAYA WAY CITY: LAS VEGAS STATE: NV ZIP: 89128 SC 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* Sierra Health Services, Inc. -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 826322-10-9 -------------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with the statement |_|. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. 826322-10-9 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Anthony M. Marlon, M.D. - -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America 5 SOLE VOTING POWER NUMBER OF 2,484,490 shares of Common Stock SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED BY -0- EACH REPORTING 7 SOLE DISPOSITIVE POWER PERSON 2,484,490 shares of Common Stock WITH 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,484,490 shares of Common Stock - -------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 14.1% - -------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13G CUSIP No. 826322-10-9 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Marlon Family Trust - -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION The assets of the trust have a situs in, and the trust is construed, enforced and administered according to the laws of the State of Nevada. 5 SOLE VOTING POWER NUMBER OF 644,638 shares of Common Stock SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED BY -0- EACH REPORTING 7 SOLE DISPOSITIVE POWER PERSON 644,638 shares of Common Stock WITH 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 644,638 shares of Common Stock - -------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.6% - -------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* OO *SEE INSTRUCTIONS BEFORE FILLING OUT! Item 1. (a) Name of Issuer: Sierra Health Services, Inc. (b) Address of Issuer's Principal Executive Offices: 2724 North Tenaya Way Las Vegas, Nevada 89128 Item 2. (a) Name of Persons Filing: (i) Anthony M. Marlon, M.D. ("Dr. Marlon") (ii) The Marlon Family Trust (b) Address of Principal Business Office or, if none, Residence: (i), (ii) 2724 North Tenaya Way Las Vegas, Nevada 89128 (c) Citizenship: (i) United States of America (ii) The assets of the trust have a situs in, and the trust is construed, enforced, and administered according to the laws of, the State of Nevada (d) Title of Class of Securities: Common Stock, $.005 par value (e) CUSIP Number: 826322-10-9 Item 3. This statement is filed pursuant to Rule 13d-1(c). Items 3(a) through 3(h) are, therefore, inapplicable. Item 4. Ownership (a) Amount Beneficially Owned at December 31, 1995: Amount beneficially owned by Dr. Marlon at December 31, 1995: 2,484,490 shares, including the shares described in the following two paragraphs. A total of 644,638 shares are held by The Marlon Family Trust and beneficially owned indirectly by Dr. Marlon in his capacity as co-trustee of such trust. A total of 1,833,852 shares are held indirectly through a total of twelve other trusts (the "Twelve Trusts"), and 1,000 shares are held indirectly through a limited partnership (the "Partnership") in which Dr. Marlon and his wife are the only limited partners and general partners. In addition, Dr. Marlon has a right to acquire 5,000 shares within sixty days of December 31, 1995 pursuant to options exercisable within such period. (b) Percent of Class: (i) 14.1% (ii) 3.6% (c) Number of shares as to which Dr. Marlon has: (i) sole power to vote or to direct the vote: 2,484,490 shares. (ii) shared power to vote or to direct the vote: 0 shares. (iii) sole power to dispose or to direct the disposition of: 2,484,490 shares. (iv) shared power to dispose or to direct the disposition of: 0 shares. Either of Dr. Marlon or The Marlon Family Trust may be deemed to have voting and dispositive power over the shares held by The Marlon Family Trust, and, therefore, to have beneficial ownership with respect to such shares. Dr. Marlon, as managing general partner of the Partnership, has sole voting and dispositive power over the shares held by the Partnership. Dr. Marlon may be deemed to have or share voting power and/or dispositive power over the shares held by the other trusts described in Item 4(a) and, therefore, to have beneficial ownership with respect to such shares. Item 5. Ownership of Five Percent or Less of a Class On December 31, 1995, The Marlon Family Trust owned less than five percent of the outstanding class of securities. Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification. Not applicable. This statement is filed pursuant to Rule 13d-1(c). AGREEMENT PURSUANT TO RULE 13d-1(f) Pursuant to Rule 13d-1(f)(1)(iii) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the undersigned agrees that this Amendment No. 8 to Schedule 13G is filed on behalf of each of them, and that subsequent amendments hereto shall be filed on behalf of each of them. The filing of this Amendment to Schedule 13G and amendments hereto, and the statements herein and therein, shall not be construed as an admission that any filing person or any other person named herein is, for purposes of Section 13(d), 13(g), 16(a), or 16(b) under the Exchange Act, or for any other purpose, the beneficial owner of any of the securities described herein or therein, except to the extent that a natural person is reported as having voting and dispositive power, and thus beneficial ownership for purposes of Sections 13(d) and 13(g), over securities owned directly by such person. SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 1996 ---------------------------- Date Anthony M. Marlon, M.D. ---------------------------- Anthony M. Marlon, M.D. ---------------------------- Name / Title February 9, 1996 ---------------------------- Date THE MARLON FAMILY TRUST By: Anthony M. Marlon, M.D. ----------------------------- Signature Anthony M. Marlon, Co-Trustee ----------------------------- -----END PRIVACY-ENHANCED MESSAGE-----